Viewing Study NCT06026566


Ignite Creation Date: 2025-12-24 @ 4:21 PM
Ignite Modification Date: 2025-12-29 @ 5:18 PM
Study NCT ID: NCT06026566
Status: RECRUITING
Last Update Posted: 2023-09-07
First Post: 2023-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Compatible Effect of Remimazolam Besylate Combined With Afentanil for ATI
Sponsor: Tongji Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module